(Total Views: 119)
Posted On: 03/02/2017 9:34:15 AM
Post# of 17885

$RGBP +65% huge breakout! Regen BioPharma, Inc. Licenses NR2F6 Technology for Cancer Treatment and Autoimmune Disorders to CheckPoint Immunology Inc.
http://finance.yahoo.com/news/regen-biopharma...00603.html
http://finance.yahoo.com/news/regen-biopharma...00603.html

